Shanghai Forest Cabin Cosmetics Group (SEHK:2657) Earnings Nearly Double Challenging Margin Worries

Shanghai Forest Cabin Cosmetics Group (SEHK:2657) has just posted FY 2025 first half revenue of about C¥1.1b and basic EPS of C¥1.45, with the latest trailing twelve month snapshot showing revenue of roughly C¥2.4b and EPS of C¥2.87 alongside earnings growth of 92.9% over the past year. Over the past few reporting periods the company has seen revenue move from C¥805.0m with EPS of C¥3.36 in 2023 H2 to C¥1,209.6m and EPS of C¥7.43 in 2024 H2, then to C¥1,730.96m and EPS of C¥3.74 for the trailing twelve months to 2025 H1. This sets the scene for current net profit margins that sit slightly below last year at 14.7% versus 15.4% and puts the focus squarely on how sustainably the business is converting sales into profit.

See our full analysis for Shanghai Forest Cabin Cosmetics Group.

With the headline numbers on the table, the next step is to see how this margin picture lines up with the widely followed narratives around Shanghai Forest Cabin Cosmetics Group's growth potential and earnings quality.

Curious how numbers become stories that shape markets? Explore Community Narratives

92.9% earnings growth backed by higher semiannual profit

• Net income excluding extra items for FY 2025 H1 is C¥181.8m on revenue of C¥1,051.8m, compared with C¥86.7m on C¥530.4m in FY 2024 H1 and C¥100.2m on C¥679.2m in FY 2024 H2. This sits alongside the 92.9% year on year earnings growth cited for the trailing 12 months.
• What supports a bullish view is that reported earnings growth is paired with larger profit figures, as the trailing 12 month net income excluding extra items reached C¥360.4m on C¥2,449.5m of revenue. Within this:
  • the FY 2025 H1 step up to C¥181.8m compares to C¥186.8m for FY 2024 H2 in the trailing set, showing that recent halves sit in a similar profit range even as revenue has scaled from C¥805.0m in 2023 H2 to C¥1,209.6m in 2024 H2 and C¥1,731.0m for the trailing 12 months to 2025 H1, and
  • the 92.9% earnings growth figure lines up with this pattern of higher net income, which bullish investors may interpret as evidence that profit expansion is not only coming from a single half but is reflected across the trailing period.

Margins ease to 14.7% as sales scale

• Net profit margin on the trailing 12 month numbers stands at 14.7% versus the previous 15.4%, based on C¥360.4m of net income excluding extra items on C¥2,449.5m of revenue. This sits alongside FY 2025 H1 net income of C¥181.8m on C¥1,051.8m of revenue.
• Skeptical investors might focus on this margin slip, but the figures create a mixed picture rather than a clear bearish one, because:
  • the margin movement from 15.4% to 14.7% comes while revenue in the trailing set has moved from C¥805.0m in 2023 H2 to C¥1,209.6m in 2024 H2 and then C¥1,731.0m for the trailing 12 months to 2025 H1, indicating that the business is handling a larger revenue base, and
  • the same period that shows the margin decline is also where earnings growth is reported at 92.9%, so critics who worry that profitability is weakening see that absolute earnings are still higher even with a slightly lower percentage margin.

Mixed valuation signals at 22.8x P/E

• At a share price of HK$65.55, the company trades on a trailing P/E of 22.8x, which is below the peer average of 25.3x but above the Asian Personal Products industry average of 21.0x. The same dataset shows a DCF fair value of HK$285.14, placing the current price about 77% below that DCF fair value estimate.
• What stands out for a general market view is the contrast between the DCF and multiples, as:
  • the large gap between HK$65.55 and the HK$285.14 DCF fair value suggests one valuation method sees significant headroom, yet
  • the 22.8x P/E sitting between peers at 25.3x and the broader industry at 21.0x implies the market is pricing the company between direct comparables and the wider group, while earnings growth of 92.9% over the past year and current margins of 14.7% provide the operating backdrop for that pricing.

If you want to see how other investors connect these earnings, margins, and valuation gaps into a bigger picture story, 📊 Read the what the Community is saying about Shanghai Forest Cabin Cosmetics Group.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Shanghai Forest Cabin Cosmetics Group's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Seeing upbeat figures and mixed signals across earnings, margins, and valuation, it makes sense to review the details yourself and decide quickly where you stand. To understand what the optimism is based on, take a closer look at the company's 3 key rewards

See What Else Is Out There

Despite strong earnings growth, Shanghai Forest Cabin Cosmetics Group carries a P/E of 22.8x and a margin slip to 14.7%, which may leave value focused investors cautious.

If that mix of rich pricing and softer profitability margins feels uncomfortable, broaden your watchlist and compare it with 229 high quality undervalued stocks

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com